3,983 Shares in CME Group Inc. $CME Purchased by Signal Advisors Wealth LLC

Signal Advisors Wealth LLC purchased a new position in CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 3,983 shares of the financial services provider’s stock, valued at approximately $1,043,000.

Several other institutional investors also recently added to or reduced their stakes in CME. Whipplewood Advisors LLC boosted its position in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 83 shares during the period. First Community Trust NA acquired a new stake in shares of CME Group in the third quarter worth $26,000. North Point Portfolio Managers Corp OH acquired a new stake in shares of CME Group in the third quarter worth $26,000. Mowery & Schoenfeld Wealth Management LLC bought a new position in CME Group during the second quarter worth $28,000. Finally, Bayban bought a new position in CME Group during the fourth quarter worth $31,000. 87.75% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Piper Sandler cut their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research note on Wednesday, July 15th. The Goldman Sachs Group reduced their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Wells Fargo & Company raised their price target on shares of CME Group from $301.00 to $315.00 and gave the stock an “overweight” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft lowered shares of CME Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $286.00 to $270.00 in a research report on Wednesday, August 19th. Finally, Raymond James Financial restated an “outperform” rating and set a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average target price of $292.94.

Insider Activity at CME Group

In other news, Director William Shepard bought 293 shares of the business’s stock in a transaction that occurred on Friday, September 25th. The stock was acquired at an average cost of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the purchase, the director owned 263,289 shares of the company’s stock, valued at $70,761,551.64. This trade represents a 0.11% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Elizabeth Cook sold 500 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $280.11, for a total value of $140,055.00. Following the completion of the transaction, the director directly owned 17,916 shares of the company’s stock, valued at approximately $5,018,450.76. This trade represents a 2.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by corporate insiders.

CME Group Trading Up 1.4%

CME Group stock opened at $289.46 on Friday. The business has a 50 day moving average price of $273.52 and a two-hundred day moving average price of $270.60. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The stock has a market cap of $104.08 billion, a price-to-earnings ratio of 24.55, a price-to-earnings-growth ratio of 3.74 and a beta of 0.24.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%. The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the company earned $2.96 EPS. The company’s quarterly revenue was up .8% on a year-over-year basis. As a group, equities analysts forecast that CME Group Inc. will post 12.29 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Wednesday, September 9th. CME Group’s dividend payout ratio is presently 44.11%.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.